The Vanguard Group 13D and 13G filings for PTC Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:12 pm Purchase |
2023-12-29 | 13G | PTC Therapeutics, Inc. PTCT |
The Vanguard Group | 8,800,843 11.660% |
1,461,323 (+19.91%) |
Filing |
| 2023-02-09 11:30 am Purchase |
2022-12-30 | 13G | PTC Therapeutics, Inc. PTCT |
The Vanguard Group | 7,339,520 10.210% |
155,828 (+2.17%) |
Filing |
| 2022-07-11 1:13 pm Purchase |
2022-06-30 | 13G | PTC Therapeutics, Inc. PTCT |
The Vanguard Group | 7,183,692 10.070% |
294,783 (+4.28%) |
Filing |
| 2022-02-10 08:32 am Purchase |
2021-12-31 | 13G | PTC Therapeutics, Inc. PTCT |
The Vanguard Group | 6,888,909 9.740% |
687,942 (+11.09%) |
Filing |
| 2021-02-10 11:40 am Purchase |
2020-12-31 | 13G | PTC Therapeutics, Inc. PTCT |
The Vanguard Group | 6,200,967 9.090% |
759,327 (+13.95%) |
Filing |